Antitumour immunity--1. Differential response of neuraminidase-treated and x-irradiated tumour vaccine.
D000818:Animals; D000951:Antigens, Neoplasm; D001555:Benzene Derivatives; D002273:Carcinogens; D002452:Cell Count; D005354:Fibrosarcoma / Q000139:chemically induced / Q000276:immunology* / Q000517:prevention & control; D006084:Graft Rejection; D007114:Immunization; D066298:In Vitro Techniques; D007279:Injections, Subcutaneous; D051379:Mice; D009281:Naphthalenes; D009368:Neoplasm Transplantation; D009439:Neuraminidase / Q000494:pharmacology*; D011829:Radiation Dosage; D011830:Radiation Effects; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000276:immunology / Q000517:prevention & control; D013876:Thiophenes; D014612:Vaccines / Q000528:radiation effects*; D014734:Vibrio cholerae / Q000201:enzymology; D014965:X-Rays
D000951:Antigens, Neoplasm; D001555:Benzene Derivatives; D002273:Carcinogens; D009281:Naphthalenes; D013876:Thiophenes; D014612:Vaccines; D009439:Neuraminidase